Marinus Pharmaceuticals Inc
(NASDAQ : MRNS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.06%16.7214.1%$331.75m
SHPGShire PLC Sponsored ADR
-0.25%149.400.4%$213.81m
PRGOPerrigo Co. Plc
0.40%87.056.6%$136.90m
MNKMallinckrodt Plc
-0.42%21.2818.5%$122.88m
SAGESAGE Therapeutics, Inc.
-0.62%94.8510.9%$110.10m
JAZZJazz Pharmaceuticals Plc
0.73%139.052.2%$78.77m
ENDPEndo International Plc
1.84%7.778.9%$70.55m
PCRXPacira Pharmaceuticals, Inc.
1.18%45.0310.7%$50.60m
ICPTIntercept Pharmaceuticals, Inc.
1.38%63.1022.0%$49.59m
UTHRUnited Therapeutics Corporation
-0.71%124.5214.5%$48.50m
ADMSAdamas Pharmaceuticals, Inc.
-1.76%33.0016.9%$43.28m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.28%128.007.6%$40.21m
MDCOMedicines Company
-0.70%31.1822.1%$39.88m
ICLRICON Plc
0.08%118.454.1%$39.03m
CTLTCatalent Inc
1.18%39.382.6%$34.24m

Company Profile

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of neuropsychiatric therapeutics. Its clinical stage drug candidate, ganaxolone, is a novel synthetic small molecule that is an analog of allopregnanolone, a natural occurring neurosteriod produced by the human body, which modulates gamma-aminobutyric acid a neurotransmitter in the brain. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.